Skip to main content
TipRanks
Go Ultimate75% OFF

Laboratorios Farmaceuticos Rovi (41L) Q4 2023 Earnings Report

4 Followers

DE:41L Q4 2023 EPS Results

Actual EPS
EUR 0.99
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
EUR 1.46

DE:41L Q4 2023 Revenue Results

Actual Revenue
EUR 234.64M
Expected Revenue
EUR 223.60M
Beat/Miss
Beat by +EUR 11.04M
YoY Revenue Growth
-3.12%

Earnings Announcement Details

Quarter
Q4 2023
Date
02/27/2024
Time
Before Open
Conference Call
Tuesday, February 27, 2024
DE:41L Upcoming Earnings

Laboratorios Farmaceuticos Rovi's next earnings date is estimated for February 24, 2027, based on past reporting schedules.

Q4 2023 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:41L Earnings History

DE:41L earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 24, 20272026 (Q4)―-0.83――
Nov 05, 20262026 (Q3)―1.531.1335.19% (+0.40)
Jul 23, 20262026 (Q2)―1.470.42246.57% (+1.04)
May 06, 20262026 (Q1)―0.180.35-47.74% (-0.17)
Feb 25, 20262025 (Q4)―0.830.4682.49% (+0.38)
Nov 06, 20252025 (Q3)―1.130.8631.86% (+0.27)
Jul 24, 20252025 (Q2)―0.420.86-50.81% (-0.44)
May 08, 20252025 (Q1)―0.350.2922.49% (+0.07)
Feb 25, 20252024 (Q4)―0.460.99-54.02% (-0.54)
Nov 07, 20242024 (Q3)―1.360.9839.47% (+0.39)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed